
A Vaidheesh, managing director, Johnson & Johnson Medical India, shares with Soma Das of FE, the strides his firm has…

A Vaidheesh, managing director, Johnson & Johnson Medical India, shares with Soma Das of FE, the strides his firm has…

Just like our people, every Indian-origin drug will be counted and have its history documented soon. From July, each drug…

The R65 crore Indian personal care products brand ?Nomarks? from the pharma and FMCG group Ozone Pharma would hit the…

Rachael Fay, an India-born Australian, returned to her country of birth about four years back to get an accurate diagnosis…

Drug makers have urged the commerce ministry to delay the date of mandating track and trace technology on drug exports…

About 81 years ago, Himalaya Healthcare founder M Manal, on his visit to Myanmar discovered a root which was being…

From the Land of the Rising Sun come rays of hope for India?s Pharma Inc. Following the India-Japan free trade…

Lupin?s net profit for the financial year ended March 31, 2011, grew 27% to touch R862.55 crore, compared to R681.63…

As reverse innovation finds its way into the FMCG sector, multinationals swear by their made-in-India brands. Many of them are…

It?s Mayday, literally, for Ayurveda-based products. Starting this month, the European market have become out of bounds for the entire…

Faced with the threat of a big price competition from the generics industry for a clutch of their blockbuster drugs…

DRUGMAKER Mylan Pharma’s lawsuit to strip Ranbaxy of its ?statutory hard-earned? 180 days of marketing exclusivity in case of the…

US generics firm Mylan, with an annual turnover of over $5 billion, is having to recall two batches of diabetes…

Shortly after putting in place a mechanism to outsource prior art searches to Council of Scientific and Industrial Research, the…

Hyderabad-based drugmaker Dr Reddy?s Labs has been sued by the largest Japanese pharma firm, Takeda Pharma, in the US for…

The call to firm up a cashless treatment scheme for all in case of critical illnesses that is funded by…

Despite the rupee appreciating against the dollar by around 1.4%, domestic pharma companies may post revenue growth in the range…

The $15.8 billion Medtronic, the largest medical product and equipment company globally had started its journey six decades back in…